Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mike J. Mwanga"'
Autor:
Mike J. Mwanga, Arnold W. Lambisia, John Mwita Morobe, Nickson Murunga, Edidah Moraa, Leonard Ndwiga, Robinson Cheruiyot, Jennifer Musyoki, Martin Mutunga, Laura M. Guzman-Rincon, Charles Sande, Joseph Mwangangi, Philip Bejon, Lynette Isabella Ochola-Oyier, D. James Nokes, Charles N. Agoti, Joyce Nyiro, George Githinji
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 11, Pp 2376-2379 (2023)
We report a newly emerged SARS-CoV-2 Omicron subvariant FY.4 that has mutations Y451H in spike and P42L in open reading frame 3a proteins. FY.4 emergence coincided with increased SARS-CoV-2 cases in coastal Kenya during April–May 2023. Continued SA
Externí odkaz:
https://doaj.org/article/83c2a85256a44925a452598a06b31efa
Autor:
Mike J. Mwanga, Betty E. Owor, John B. Ochieng, Mwanajuma H. Ngama, Billy Ogwel, Clayton Onyango, Jane Juma, Regina Njeru, Elijah Gicheru, Grieven P. Otieno, Sammy Khagayi, Charles N. Agoti, Godfrey M. Bigogo, Richard Omore, O. Yaw Addo, Seheri Mapaseka, Jacqueline E. Tate, Umesh D. Parashar, Elizabeth Hunsperger, Jennifer R. Verani, Robert F. Breiman, D. James Nokes
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
Abstract Background Kenya introduced the monovalent G1P [8] Rotarix® vaccine into the infant immunization schedule in July 2014. We examined trends in rotavirus group A (RVA) genotype distribution pre- (January 2010–June 2014) and post- (July 2014
Externí odkaz:
https://doaj.org/article/03613fb1debe4f228aa55187f987d5b8
Autor:
Betty E. Owor, Mike J. Mwanga, Regina Njeru, Robert Mugo, Mwanajuma Ngama, Grieven P. Otieno, D.J. Nokes, C.N. Agoti
Publikováno v:
Wellcome Open Research, Vol 3 (2019)
Background: Kenya introduced the monovalent Rotarix® rotavirus group A (RVA) vaccine nationally in mid-2014. Long-term surveillance data is important prior to wide-scale vaccine use to assess the impact on disease and to investigate the occurrence o
Externí odkaz:
https://doaj.org/article/df02b4591da543b581ab7b1c91002bb3
Autor:
Mike J. Mwanga, Jennifer R. Verani, Richard Omore, Jacqueline E. Tate, Umesh D. Parashar, Nickson Murunga, Elijah Gicheru, Robert F. Breiman, D. James Nokes, Charles N. Agoti
Publikováno v:
Pathogens, Vol 9, Iss 12, p 981 (2020)
Globally, rotavirus group A (RVA) remains a major cause of severe childhood diarrhea, despite the use of vaccines in more than 100 countries. RVA sequencing for local outbreaks facilitates investigation into strain composition, origins, spread, and v
Externí odkaz:
https://doaj.org/article/05700097561b4c3a86e808dcded99f2c
Autor:
Betty E. Owor, Mike J. Mwanga, Regina Njeru, Robert Mugo, Mwanajuma Ngama, Grieven P. Otieno, D.J. Nokes, C.N. Agoti
Publikováno v:
Wellcome Open Research, Vol 3 (2018)
Background: Kenya introduced the monovalent Rotarix® rotavirus group A (RVA) vaccine nationally in mid-2014. Long-term surveillance data is important prior to wide-scale vaccine use to assess the impact on disease and to investigate the occurrence o
Externí odkaz:
https://doaj.org/article/134423b022b54121b672e853eca0674b
Autor:
Timothy O Makori, Joel L Bargul, Arnold W Lambisia, Mike J Mwanga, Nickson Murunga, Zaydah R de Laurent, Clement S Lewa, Martin Mutunga, Paul Kellam, Matthew Cotten, D James Nokes, My Phan, Charles N Agoti
Publikováno v:
Virus Evolution. 9
The introduction of rotavirus vaccines into the national immunization programme in many countries has led to a decline in childhood diarrhoea disease burden. Coincidentally, the incidence of some rotavirus group A (RVA) genotypes has increased, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::329688a1bd596e5184e0b7034c89b30d
https://doi.org/10.1093/ve/vead025
https://doi.org/10.1093/ve/vead025
Autor:
Timothy O. Makori, Joel L. Bargul, Arnold W. Lambisia, Mike J. Mwanga, Nickson Murunga, Zaydah R. de Laurent, Clement S. Lewa, Martin Mutunga, Paul Kellam, Matthew Cotten, D. James Nokes, My Phan, Charles N. Agoti
The introduction of rotavirus vaccines into the national immunization programme in many countries has led to a decline of childhood diarrhoea disease burden. Coincidentally, the incidence of some rotavirus group A (RVA) genotypes, has increased, whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::412f300137f79fcd21da8362af099007
https://doi.org/10.1101/2022.10.21.22281210
https://doi.org/10.1101/2022.10.21.22281210
Autor:
Nickson Murunga, Umesh D. Parashar, Mike J. Mwanga, Richard Omore, Charles N. Agoti, D. James Nokes, Elijah Gicheru, Jennifer R. Verani, Robert F. Breiman, Jacqueline E. Tate
Publikováno v:
Pathogens
Volume 9
Issue 12
Pathogens, Vol 9, Iss 981, p 981 (2020)
Volume 9
Issue 12
Pathogens, Vol 9, Iss 981, p 981 (2020)
Globally, rotavirus group A (RVA) remains a major cause of severe childhood diarrhea, despite the use of vaccines in more than 100 countries. RVA sequencing for local outbreaks facilitates investigation into strain composition, origins, spread, and v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7027003e108a290015b01cda6d5d90c0
Autor:
Breiman Rf, Murunga N, Agoti Cn, Mike J. Mwanga, Parashar Ud, Nokes Dj, Tate Je, Verani, Gicheru E, Omore R
Globally, rotavirus group A (RVA) remains a major cause of severe childhood diarrhea, despite the use of vaccines in > 100 countries. RVA sequencing for local outbreaks facilitates investigation into strain composition, origins, spread, and vaccine f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6564c77cf5e03cf42f4bcd60a5228be
https://doi.org/10.20944/preprints202010.0470.v1
https://doi.org/10.20944/preprints202010.0470.v1
Autor:
Seheri L. Mapaseka, Umesh D. Parashar, Regina Njeru, Mike J. Mwanga, John B. Ochieng, Betty E Owor, Jane Juma, Godfrey Bigogo, Grieven P. Otieno, Mwanajuma Ngama, Billy Ogwel, D. James Nokes, Jennifer R. Verani, Richard Omore, Charles N. Agoti, Robert F. Breiman, Sammy Khagayi, Jacqueline E. Tate, Clayton Onyango, Elizabeth Hunsperger, O. Yaw Addo, Elijah Gicheru
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-12 (2020)
Background Kenya introduced the monovalent G1P [8] Rotarix® vaccine into the infant immunization schedule in July 2014. We examined trends in rotavirus group A (RVA) genotype distribution pre- (January 2010–June 2014) and post- (July 2014–Decemb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d58abca2f3abc94e32b09f5bece7a116
https://doi.org/10.21203/rs.2.24781/v1
https://doi.org/10.21203/rs.2.24781/v1